BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 20921626)

  • 21. p53-TP53-Induced Glycolysis Regulator Mediated Glycolytic Suppression Attenuates DNA Damage and Genomic Instability in Fanconi Anemia Hematopoietic Stem Cells.
    Li X; Wu L; Zopp M; Kopelov S; Du W
    Stem Cells; 2019 Jul; 37(7):937-947. PubMed ID: 30977208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient-derived C-terminal mutation of FANCI causes protein mislocalization and reveals putative EDGE motif function in DNA repair.
    Colnaghi L; Jones MJ; Cotto-Rios XM; Schindler D; Hanenberg H; Huang TT
    Blood; 2011 Feb; 117(7):2247-56. PubMed ID: 20971953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolyl isomerization of FAAP20 catalyzed by PIN1 regulates the Fanconi anemia pathway.
    Wang J; Chan B; Tong M; Paung Y; Jo U; Martin D; Seeliger M; Haley J; Kim H
    PLoS Genet; 2019 Feb; 15(2):e1007983. PubMed ID: 30789902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fanconi Anemia: A DNA repair disorder characterized by accelerated decline of the hematopoietic stem cell compartment and other features of aging.
    Brosh RM; Bellani M; Liu Y; Seidman MM
    Ageing Res Rev; 2017 Jan; 33():67-75. PubMed ID: 27223997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FANCJ suppresses microsatellite instability and lymphomagenesis independent of the Fanconi anemia pathway.
    Matsuzaki K; Borel V; Adelman CA; Schindler D; Boulton SJ
    Genes Dev; 2015 Dec; 29(24):2532-46. PubMed ID: 26637282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia.
    Río P; Navarro S; Wang W; Sánchez-Domínguez R; Pujol RM; Segovia JC; Bogliolo M; Merino E; Wu N; Salgado R; Lamana ML; Yañez RM; Casado JA; Giménez Y; Román-Rodríguez FJ; Álvarez L; Alberquilla O; Raimbault A; Guenechea G; Lozano ML; Cerrato L; Hernando M; Gálvez E; Hladun R; Giralt I; Barquinero J; Galy A; García de Andoín N; López R; Catalá A; Schwartz JD; Surrallés J; Soulier J; Schmidt M; Díaz de Heredia C; Sevilla J; Bueren JA
    Nat Med; 2019 Sep; 25(9):1396-1401. PubMed ID: 31501599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells.
    Rathbun RK; Faulkner GR; Ostroski MH; Christianson TA; Hughes G; Jones G; Cahn R; Maziarz R; Royle G; Keeble W; Heinrich MC; Grompe M; Tower PA; Bagby GC
    Blood; 1997 Aug; 90(3):974-85. PubMed ID: 9242526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
    Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
    Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fanconi anemia: at the crossroads of DNA repair.
    Deakyne JS; Mazin AV
    Biochemistry (Mosc); 2011 Jan; 76(1):36-48. PubMed ID: 21568838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TNF-α signaling in Fanconi anemia.
    Du W; Erden O; Pang Q
    Blood Cells Mol Dis; 2014 Jan; 52(1):2-11. PubMed ID: 23890415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fanconi anemia: a signal transduction and DNA repair pathway.
    Kupfer GM
    Yale J Biol Med; 2013 Dec; 86(4):491-7. PubMed ID: 24348213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24.
    Kim JM; Kee Y; Gurtan A; D'Andrea AD
    Blood; 2008 May; 111(10):5215-22. PubMed ID: 18174376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FANCI is a second monoubiquitinated member of the Fanconi anemia pathway.
    Sims AE; Spiteri E; Sims RJ; Arita AG; Lach FP; Landers T; Wurm M; Freund M; Neveling K; Hanenberg H; Auerbach AD; Huang TT
    Nat Struct Mol Biol; 2007 Jun; 14(6):564-7. PubMed ID: 17460694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors.
    Galimi F; Noll M; Kanazawa Y; Lax T; Chen C; Grompe M; Verma IM
    Blood; 2002 Oct; 100(8):2732-6. PubMed ID: 12351379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fanconi anemia signaling network regulates the spindle assembly checkpoint.
    Nalepa G; Enzor R; Sun Z; Marchal C; Park SJ; Yang Y; Tedeschi L; Kelich S; Hanenberg H; Clapp DW
    J Clin Invest; 2013 Sep; 123(9):3839-47. PubMed ID: 23934222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg.
    Reliene R; Yamamoto ML; Rao PN; Schiestl RH
    Cancer Res; 2010 Dec; 70(23):9703-10. PubMed ID: 21118969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update of the human and mouse Fanconi anemia genes.
    Dong H; Nebert DW; Bruford EA; Thompson DC; Joenje H; Vasiliou V
    Hum Genomics; 2015 Nov; 9():32. PubMed ID: 26596371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fanconi anemia.
    Green AM; Kupfer GM
    Hematol Oncol Clin North Am; 2009 Apr; 23(2):193-214. PubMed ID: 19327579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impairment of fetal hematopoietic stem cell function in the absence of Fancd2.
    Suzuki S; Racine RR; Manalo NA; Cantor SB; Raffel GD
    Exp Hematol; 2017 Apr; 48():79-86. PubMed ID: 27915139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1.
    Parmar K; Kim J; Sykes SM; Shimamura A; Stuckert P; Zhu K; Hamilton A; Deloach MK; Kutok JL; Akashi K; Gilliland DG; D'andrea A
    Stem Cells; 2010 Jul; 28(7):1186-95. PubMed ID: 20506303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.